■ MATERIAL WEAKNESS WATCH
Nasdaq · CIK 0001611115

OMDA Omada Health, Inc.

D
55 / 100
Material weaknesses
3
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
1
Deductions
60
Remediation credit
15

Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.

Disclosures, in the company's words

  • Material weakness10-Q · filed 2026-11-06 · Item 4source filing ↗
    “Management identified control deficiencies related to inadequate formalized processes and control activities to support the financial close and reporting process, including the review of financial information, account analysis, and journal entries.”
  • Material weakness10-Q · filed 2026-11-06source filing ↗
    “We have identified a material weakness in our internal control over financial reporting. If our remediation of the material weakness is not effective, or if we experience additional material weaknesses in the future”
  • Material weakness10-Q · filed 2026-11-06 · Item 4source filing ↗
    “we previously identified a material weakness in our internal control over financial reporting related to inadequate formalized processes and control activities to support the financial close and reporting process, including the review of financial information, account analysis, and journal entries.”
  • Controls not effective10-Q · filed 2026-11-06 · Item 4source filing ↗
    “Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of September 30, 2026, our disclosure controls and procedures were not effective at the reasonable assurance level because of the material weakness in our internal control over financial reporting described below.”

Remediation disclosed

  • 10-Q · filed 2026-11-06 · source filing ↗
    “The material weakness resulted in adjustments to the financial statements for the year ended December 31, 2025, and, together with certain other material weaknesses previously identified that have since been remediated, the financial statements for the year ended December 31, 2023 and 2024.”

Filings read

Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.